Compare Ascendis Pharma A/S (ASND) vs Consolidated Edison, Inc. (ED) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs Consolidated Edison, Inc. — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while Consolidated Edison, Inc. trades at $107.5 (market cap $39.76B). The key difference: Consolidated Edison, Inc. is far larger — about 2.4× Ascendis Pharma A/S's market cap, and Consolidated Edison, Inc. pays a 3.27% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | ED | |
|---|---|---|
Market Cap | $16.67B | $39.76B |
Sector | Health | Utilities |
52-Week High | $277.18 | $115.46 |
52-Week Low | $189.74 | $95.37 |
Enterprise Value | $17.04B | $66.61B |
Dividend Yield | — | 3.27% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About Consolidated Edison, Inc.
Con Ed is a holding company for Consolidated Edison of New York, or CECONY, and Orange & Rockland, or O&R. These utilities provide steam, natural gas, and electricity to customers in southeastern New York—including New York City—and small parts of New Jersey. The two utilities will generate nearly all of Con Ed's earnings once it closes the sale of its clean energy business to RWE. Con Ed's clean energy business owns the second-largest portfolio of utility-scale solar projects in the U.S. Following the sale, Con Ed's only non-utility earnings will come from investments in gas and electric transmission.
Read more on ED →
